Tilray Brands, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Tilray Brands, Inc. (TLRY) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $19.40 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-07-28
- Tilray Brands, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-05-31 was $40.35M, a 168.60% increase year-over-year.
- Tilray Brands, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-02-28 was -$10.64M.
- Tilray Brands, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-11-30 was -$5.18M.
- Tilray Brands, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-08-31 was -$5.13M.
- Tilray Brands, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2026 was $19.40M.
- Tilray Brands, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was -$22.94M, a 10919.81% decline from fiscal 2024.
- Tilray Brands, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $212.00K, a 98.94% decline from fiscal 2023.
- Tilray Brands, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $20.04M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-05-31 | $40.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $29.71M derived: sum of 2 quarters · filed 2026-07-28 | $24.53M derived: sum of 3 quarters · filed 2026-07-28 | $19.40M 10-K · filed 2026-07-28 | |
| 2026-02-28 | -$10.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | -$15.82M derived: sum of 2 quarters · filed 2026-04-01 | -$20.95M 10-Q · filed 2026-04-01 | -$5.93M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2025-11-30 | -$5.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | -$10.31M 10-Q · filed 2026-01-08 | $4.71M derived: sum of 3 quarters · filed 2026-07-28 | -$8.42M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2025-08-31 | -$5.13M 10-Q · filed 2025-10-09 | $9.89M derived: sum of 2 quarters · filed 2026-07-28 | -$3.24M derived: sum of 3 quarters · filed 2026-07-28 | -$19.59M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2025-05-31 | $15.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $1.89M derived: sum of 2 quarters · filed 2026-07-28 | -$14.47M derived: sum of 3 quarters · filed 2026-07-28 | -$22.94M 10-K · filed 2026-07-28 | |
| 2025-02-28 | -$13.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | -$29.49M derived: sum of 2 quarters · filed 2026-04-01 | -$37.96M 10-Q · filed 2026-04-01 | -$6.77M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2024-11-30 | -$16.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | -$24.83M 10-Q · filed 2026-01-08 | $6.37M derived: sum of 3 quarters · filed 2026-07-28 | -$171.00K derived: sum of 4 quarters · filed 2026-07-28 | |
| 2024-08-31 | -$8.47M 10-Q · filed 2025-10-09 | $22.72M derived: sum of 2 quarters · filed 2026-07-28 | $16.18M derived: sum of 3 quarters · filed 2026-07-28 | -$1.79M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2024-05-31 | $31.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $24.66M derived: sum of 2 quarters · filed 2026-07-28 | $6.68M derived: sum of 3 quarters · filed 2026-07-28 | $212.00K 10-K · filed 2026-07-28 | |
| 2024-02-29 | -$6.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-08 | -$24.51M derived: sum of 2 quarters · filed 2025-04-08 | -$30.98M 10-Q · filed 2025-04-08 | -$9.52M derived: sum of 4 quarters · filed 2025-07-29 | |
| 2023-11-30 | -$17.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-10 | -$24.45M 10-Q · filed 2025-01-10 | -$2.98M derived: sum of 3 quarters · filed 2025-07-29 | -$2.46M derived: sum of 4 quarters · filed 2025-07-29 | |
| 2023-08-31 | -$6.47M 10-Q · filed 2024-10-10 | $14.99M derived: sum of 2 quarters · filed 2025-07-29 | $15.52M derived: sum of 3 quarters · filed 2025-07-29 | $19.84M derived: sum of 4 quarters · filed 2025-07-29 | |
| 2023-05-31 | $21.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | $21.98M derived: sum of 2 quarters · filed 2025-07-29 | $26.31M derived: sum of 3 quarters · filed 2025-07-29 | $20.04M 10-K · filed 2025-07-29 | |
| 2023-02-28 | $522.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09 | $4.85M derived: sum of 2 quarters · filed 2024-04-09 | -$1.42M 10-Q · filed 2024-04-09 | $11.88M derived: sum of 4 quarters · filed 2024-10-10 | |
| 2022-11-30 | $4.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-09 | -$1.94M 10-Q · filed 2024-01-09 | $11.35M derived: sum of 3 quarters · filed 2024-10-10 | -$2.08M derived: sum of 4 quarters · filed 2024-10-10 | |
| 2022-08-31 | -$6.26M 10-Q · filed 2024-10-10 | $7.03M derived: sum of 2 quarters · filed 2024-10-10 | -$6.40M derived: sum of 3 quarters · filed 2024-10-10 | -$28.32M derived: sum of 4 quarters · filed 2024-10-10 | |
| 2022-05-31 | $13.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | -$139.00K derived: sum of 2 quarters · filed 2024-07-30 | -$22.05M derived: sum of 3 quarters · filed 2024-07-30 | -$44.65M 10-K · filed 2024-07-30 | |
| 2022-02-28 | -$13.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-10 | -$35.35M derived: sum of 2 quarters · filed 2023-04-10 | -$57.95M 10-Q · filed 2023-04-10 | -$34.20M derived: sum of 4 quarters · filed 2023-07-26 | |
| 2021-11-30 | -$21.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | -$44.51M 10-Q · filed 2023-01-09 | -$20.76M derived: sum of 3 quarters · filed 2023-07-26 | -$50.70M derived: sum of 4 quarters · filed 2023-07-26 | |
| 2021-08-31 | -$22.60M 10-Q · filed 2022-10-07 | $1.15M derived: sum of 2 quarters · filed 2023-07-26 | -$28.79M derived: sum of 3 quarters · filed 2023-07-26 | $11.37M derived: sum of 4 quarters · filed 2023-07-26 | |
| 2021-05-31 | $23.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | -$6.19M derived: sum of 2 quarters · filed 2023-07-26 | $33.97M derived: sum of 3 quarters · filed 2023-07-26 | $14.63M 10-K · filed 2023-07-26 | $14.50M 10-K · filed 2021-07-28 |
| 2021-02-28 | -$29.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-06 | $10.22M derived: sum of 2 quarters · filed 2022-04-06 | -$9.11M 10-Q · filed 2022-04-06 | ||
| 2020-11-30 | $40.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-10 | $20.83M 10-Q · filed 2022-01-10 | |||
| 2020-08-31 | -$19.34M 10-Q · filed 2021-10-07 | ||||
| 2020-05-31 | $47.32M 10-K · filed 2022-07-28 | $47.34M 10-K · filed 2021-07-28 | |||
| 2019-05-31 | -$8.98M 10-K · filed 2021-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |